Abstract
We managed a peculiar case of lymphoma showing immunohistochemical overexpression of cyclin D1. At initial examination the patient had meningeal lymphomatosis and general lymphadenopathy. Histologic examination of biopsy specimens of inguinal lymph nodes showed tumor cells and vague nodular growth resembling lymphoblasts. The results of flow cytometric analysis were positive for CD10, CD20, CD103, and immunoglobulin G (IgG) and Igκ and were negative for CD5, CD23, and terminal deoxynucleotidyl transferase activity. Results of immunohistochemical analysis of paraffin-embedded specimens were positive for cyclin D1 and Bc12 in the tumor cells. Sixty percent of tumor cells had positive results for MIB1/Ki67. Cytogenetic and molecular studies revealed tumor cells simultaneously had t(14;18)(q32;q21), t(11;22)(q13;q11), t(8;14)(q24;q32), and t(3;14)(q27;q32) with the rearrangement of BCL1, BCL2, BCL6, and c-MYC genes. Lymphadenopathy showed a quick and complete response to doxorubicin-containing systemic chemotherapy with rituximab, but the central nervous system disease progressed and killed the patient.
Similar content being viewed by others
References
Solomon E, Borrow J, Goddard AD. Chromosomal aberrations and cancer. Science. 1991;254:1153–1160.
Nakamura S, Yatabe Y, Kuroda H, et al. Immunostaining of PRAD1/cyclin D1 protein as a marker for the diagnosis of mantle cell lymphoma. Leukemia. 1997;11:536–537.
Nakamura S, Shiota M, Nakagawa A, et al. Anaplastic large cell lymphoma: a distinct molecular pathologic entity: a reappraisal with special reference to p80 (NPM/ALK) expression. Am J Surg Pathol. 1997;21:1420–1432.
Swerdlow SH, Berger F, Issacson PI, et al. Mantle cell lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. Pathology and Genetics: Tumors of Haematopoietic and Lymphoid Tissues— World Health Organization Classification of Tumors. Lyon, France:IARC Press; 2001:168–170.
Takahashi N, Nakai S, Honjo T. Cloning of human immunoglobulin mu gene and comparison with mouse mu genes. Nucleic Acids Res. 1980;8:5983–5991.
Tsujimoto Y, Cossman J, Jaffe E, Croce CM. Involvement of the bcl-2 gene in human follicular lymphoma. Science. 1985;228:1440–1443.
Crescenzi M, Seto M, Herzig GP, Weiss PD, Griffith RC, Korsmeyer SJ. Thermostable DNA polymerase chain amplification of t(14;18) chromosome breakpoints and detection of minimal residual disease. Proc Natl Acad Sci USA. 1988;85:4869–4873.
Bergsagel PL, Chesi M, Nardini E, Brents LA, Kirby SL, Kuehl WM. Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma. Proc Natl Acad Sci USA. 1996;93:13931–13936.
Miki T, Kawamata N, Arai A, et al. Molecular cloning of the breakpoint for 3q27 translocation in B-cell lymphomas and leukemias. Blood. 1994;83:217–222.
Nomura K, Yoshino T, Nakamura S, et al. Detection of t(11;18) (q21;q21) in marginal zone lymphoma of mucosa-associated lymphocytic tissue type on paraffin-embedded tissue sections by using fluorescence in situ hybridization. Cancer Genet Cytogenet. 2003;140:49–54.
Tsujimoto Y, Jaffe E, Cossman J, Gorham J, Nowell PC, Croce CM. Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11;14) chromosome translocation. Nature. 1985;315:340–343.
Motokura T, Bloom T, Kim HG, et al. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature. 1991;350:512–515.
Willis TG, Jadayel DM, Coignet LJ, et al. Rapid molecular cloning of rearrangements of the IGH J locus using long-distance inverse polymerase chain reaction. Blood. 1997;90:2456–2464.
Karsan A, Gascoyne RD, Coupland RW, Shepherd JD, Phillips GL. Combination of t(4;18) and a Burkitt’s type translocation in B-cell malignancies. Leuk Lymphoma. 1993;10:433–441.
Sonoki T, Siebert R, Taniguchi I, Hata H, Dyer MJS, Mitsuya H. Activation of MYC by cytogenetically cryptic chromosome translocation, t(8;17)(q24;q22). Ann Oncol. 2002;13(suppl 2):50.
Komatsu H, Yoshida K, Seto M, et al. Overexpression of PRAD1 in a mantle zone lymphoma patient with a t(11;22)(q13;q11) translocation. Br J Haematol. 1993;85:427–429.
Oinonen R, Franssila K, Elonen E. Central nervous system involvement in patients with mantle cell lymphoma. Ann Hematol. 1999;78:145–149.
Dong HY, Gorczyca W, Liu Z, et al. B-cell lymphomas with coexpression of CD5 and CD10. Am J Clin Pathol. 2003;119:218–230.
Dyer MJS. The pathogenetic role of oncogenes deregulated by chromosomal translocation in B-cell malignancies. Int J Hematol. 2003;77:315–320.
Jaeger U, Karth GD, Knapp S, Friedl J, Laczika K, Kusec R. Molecular mechanism of the t(14;18): a model for lymphoid-specific chromosomal translocations. Leuk Lymphoma. 1994;14:197–202.
Tilly H, Rossai A, Stamatoullas A, et al. Prognostic value of chromosomal abnormalities in follicular lymphoma. Blood. 1994;84:1043–1049.
Limpens J, Stad R, Vos C, et al. Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. Blood. 1995;85:2528–2536.
Hao S, Sanger W, Onciu M, Lai R, Schlette EJ, Medeiros LJ. Mantle cell lymphoma with 8q24 chromosomal abnormalities: a report of 5 cases with blastoid features. Mod Pathol. 2002;15:1266–1272.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Kawakami, K., Miyanishi, S., Sonoki, T. et al. Case of B-Cell Lymphoma with Rearrangement of the BCL1, BCL2, BCL6, and c-MYC Genes. Int J Hematol 79, 474–479 (2004). https://doi.org/10.1532/IJH97.03105
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1532/IJH97.03105